What is the correct ICD (International Classification of Diseases) code for a patient with chronic gout (Gouty Arthropathy) experiencing an acute flare-up while taking colchicine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Coding for Chronic Gout with Acute Flare While on Colchicine

For a patient with chronic gout experiencing an acute flare while taking colchicine, the correct ICD-10 code is M1A.9X1 (Chronic gout, unspecified site, with tophus [tophi]) or M1A.[specific joint]1 if the joint location is known, with an additional code for the acute gout attack: M10.9 (Gout, unspecified). 1

Primary Coding Approach

  1. Primary Code for Chronic Gout:

    • M1A.9X1 - Chronic gout, unspecified site, with tophus (tophi)
    • OR use a more specific joint code if the location is known:
      • M1A.0X1 - Chronic gout of shoulder with tophus
      • M1A.1X1 - Chronic gout of elbow with tophus
      • M1A.2X1 - Chronic gout of wrist with tophus
      • M1A.3X1 - Chronic gout of hand with tophus
      • M1A.4X1 - Chronic gout of hip with tophus
      • M1A.5X1 - Chronic gout of knee with tophus
      • M1A.6X1 - Chronic gout of ankle and foot with tophus
      • M1A.7X1 - Chronic gout of ankle and foot with tophus
  2. Secondary Code for Acute Flare:

    • M10.9 - Gout, unspecified (for the acute attack)

Medication Documentation

  • Document that the patient is currently taking colchicine for gout management
  • Consider adding Z79.899 (Other long-term [current] drug therapy) to indicate ongoing colchicine therapy

Clinical Context and Management Considerations

The coding should reflect both the chronic nature of the condition and the acute exacerbation. According to guidelines, acute gout flares in patients with chronic gout should be treated promptly 1:

  • Low-dose colchicine is most effective when started within 12 hours of symptom onset
  • The recommended dosing regimen is 1.2 mg initially, followed by 0.6 mg one hour later 1, 2
  • This low-dose regimen has been shown to be as effective as higher doses with fewer side effects 2

Important Coding Pitfalls to Avoid

  1. Don't use only the acute gout code (M10.9) - This fails to capture the chronic nature of the disease
  2. Don't use only the chronic gout code - This fails to document the acute flare
  3. Don't forget to specify the joint location if known - Using unspecified codes when more specific information is available may lead to claim denials
  4. Don't overlook medication documentation - Especially important for patients with renal impairment, as colchicine dosing may need adjustment 3, 1

Special Considerations

  • If the patient has renal impairment, consider adding the appropriate N18 code series to document chronic kidney disease
  • For patients with CKD, note that low-dose colchicine is preferred over NSAIDs for acute gout flares 3
  • If the patient has cardiovascular disease, colchicine is considered safe and potentially reduces the risk of myocardial infarction 4

By using this coding approach, you will accurately document both the chronic nature of the patient's gout and the current acute flare while on colchicine therapy.

References

Guideline

Gout Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacologic Management of Gout in Patients with Cardiovascular Disease and Heart Failure.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.